Roche battles back against biosimilar impact, sales up 7%
Despite biosimilars eroding sales in Europe, Roche’s new wave of biologics saw its pharmaceutical division manage a growth of 7% in sales, globally.
Archives for January 31, 2019
Neurocrine agrees to pay up to $1.7bn in gene therapy collaboration
Neurocrine and Voyager enter an agreement to fund and develop gene therapy candidates for the treatment of severe neurological diseases.